Determinants of Monocyte Apoptosis in Cardiorenal Syndrome Type 1
- PMID: 29847820
- PMCID: PMC6170906
- DOI: 10.1159/000488949
Determinants of Monocyte Apoptosis in Cardiorenal Syndrome Type 1
Abstract
Background: Cardiorenal syndrome type 1 (CRS type 1) is characterized by a rapid worsening of cardiac function leading to acute kidney injury (AKI). Its pathophysiology is complex and not completely understood. In this study, we examined the role of apoptosis and the caspase pathways involved.
Material and methods: We enrolled 40 acute heart failure (AHF) patients, 11 of whom developed AKI characterizing CRS type 1. We exposed the human cell line U937 to plasma from the CRS type 1 and AHF groups and then we evaluated apoptotic activity by annexin-V evaluation, determination of caspase-3, -8 and -9 levels, and BAX, BAD, and FAS gene expression.
Results: We observed significant upregulation of apoptosis in monocytes exposed to CRS type 1 plasma compared to AHF, with increased levels of caspase-3 (p < 0.01), caspase-9 (p < 0.01), and caspase-8 (p < 0.03) showing activation of both intrinsic and extrinsic pathways. Furthermore, monocytes exposed to CRS type 1 plasma had increased gene expression of BAX and BAD (intrinsic pathways) (p = 0.010 for both). Furthermore, strong significant correlations between the caspase-9 levels and BAD and BAX gene expression were observed (Spearman ρ = - 0.76, p = 0.011, and ρ = - 0.72, p = 0.011).
Conclusion: CRS type 1 induces dual apoptotic pathway activation in monocytes; the two pathways converged on caspase-3. Many factors may induce activation of both intrinsic and extrinsic apoptotic pathways in CRS type 1 patients, such as upregulation of proinflammatory cytokines and hypoxia/ischemia. Further investigations are necessary to corroborate the present findings, and to better understand the pathophysiological mechanism and consequent therapeutic and prognostic implications for CRS type 1.
Keywords: Apoptosis; Cardiorenal syndrome; Caspase; Monocytes.
© 2018 S. Karger AG, Basel.
Figures
References
-
- Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol. 2008;52:1527–1539. - PubMed
-
- Haase M, Muller C, Damman K, Murray PT, Kellum JA, Ronco C, et al. Pathogenesis of cardiorenal syndrome type 1 in acute decompensated heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI) Contrib Nephrol. 2013;182:99–116. - PubMed
-
- Wang Y, Fang Y, Teng J, Ding X. Acute kidney injury epidemiology: from recognition to intervention. Contrib Nephrol. 2016;187:1–8. - PubMed
-
- Virzì GM, de Cal M, Day S, Brocca A, Cruz DN, Castellani C, et al. Pro-apoptotic effects of plasma from patients with cardiorenal syndrome on human tubular cells. Am J Nephrol. 2015;41:474–484. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous